logo
Select company
Select metric
-0.58%Buyback Yield
VS
Market
29
Sector
58
Industry
72
History
70
$ 29.46Close
$ 13.63 - $ 41.99 52-Week Range
Ticker Information

Ticker

RIGL

Company Name

RIGEL PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

RIGEL PHARMACEUTICALS INC - Buyback Yield Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RIGL - Buyback Yield Historical data
DateBuyback YieldMarket CapitalizationNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025-0.58%$ 434.8M$ 2.52M
3/31/2025-0.72%$ 326.35M$ 2.36M
12/31/2024-0.5%$ 394.41M$ 1.96M
9/30/2024-0.36%$ 271.98M$ 985K
6/30/2024-0.51%$ 164.16M$ 836K
3/31/2024-0.54%$ 208.73M$ 1.14M
12/31/2023-0.4%$ 259.56M$ 1.05M
9/30/2023-0.76%$ 151.79M$ 1.15M
6/30/2023-0.49%$ 231.9M$ 1.14M
3/31/2023-0.6%$ 197.98M$ 1.19M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • RIGEL PHARMACEUTICALS INC's latest trailing twelve months (TTM) Buyback Yield stands at -0.57%.
  • Over the past 5 years, RIGEL PHARMACEUTICALS INC's average Buyback Yield has been -0.72%.
  • The median Buyback Yield for RIGEL PHARMACEUTICALS INC during this period was -0.59%
  • RIGEL PHARMACEUTICALS INC reached its highest Buyback Yield over the past 5 years at -0.35%.
  • The lowest Buyback Yield recorded by RIGEL PHARMACEUTICALS INC in the same timeframe -2.09%

RIGEL PHARMACEUTICALS INC's Buyback Yield vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Buyback Yield Benchmarks
CompanyBuyback Yield
MRVI : MARAVAI LIFESCIENCES HOLDINGS INC 0%KROS : KEROS THERAPEUTICS INC -39.56%ARVN : ARVINAS INC -0.74%RGNX : REGENXBIO INC -0.22%VNDA : VANDA PHARMACEUTICALS INC 0%CTMX : CYTOMX THERAPEUTICS INC -27.66%XNCR : XENCOR INC -39.31%ESPR : ESPERION THERAPEUTICS INC -0.85%NKTR : NEKTAR THERAPEUTICS -0.07%PBYI : PUMA BIOTECHNOLOGY INC -0.17%

Definition of Buyback Yield

[Calculation] The Buyback Yield is a ratio that calculates the difference between the trailing twelve-month share issuances and repurchases [NCFCommon] and divides it by the [MarketCap] of the company. A negative value indicates a dilution of shareholder value and might be considered as a warning sign.
(-1 * CF - Equity) / Market Cap
(=) Buyback Yield
Buyback Yield for RIGEL PHARMACEUTICALS INC is calculated as follows: (-1 * CF - Equity [ $ 2.62M ]) / Market Cap [ $ 463.01M ]
(=) Buyback Yield [ -0.57% ]

RIGL - Buyback Yield, Last 5 years

-2.09%

Minimum

Sep 30, 2022

-0.35%

Maximum

Dec 31, 2020

-0.72%

Average

-0.59%

Median

Buyback Yield Benchmark Analysis

The chart above depicts the distribution of Buyback Yield for companies in the Total Stock Market. The average Buyback Yield of the companies is 0.64% with a standard deviation of 2.7%.
The following table provides additional summary stats:
Buyback Yield in the Market:
filtered constituents3.28K
min-8.43%
max8.43%
average0.64%
median0.01%
std2.7%